Prometheus Laboratories is enrolling patients for Proclivity 01, a multi-center study of Proleukin (High Dose Interleukin-2 (HD IL-2)) combined with vemurafenib therapy in patients with Braf V600 mutation-positive metastatic melanoma (mM). ...
Tags: Prometheus, Proclivity 01 Study
Pfizer has received breakthrough therapy designation from the United States Food and Drug Administration (FDA) for its investigational compound Palbociclib, a potential treatment for patients with breast cancer. The breakthrough therapy ...
Tags: Cancer Drug, Pfizer, Therapy Designation
In April, AATCC will honor Nicole Nichols-Wilson, president and founder of Pure Filter Solutions (PFS), as the 2012 recipient of the Association’s Young Entrepreneur Award. Nichols is being recognized for designing, manufacturing, and ...
Tags: Apparel, Textile, Nicole Wilson Bags
This year presents Amur Minerals with an opportunity to update a former pre-feasibility study for its flagship Kun Manie nickel-copper project. Analyst Tom Hayes said that drilling results in 2012 have pointed to an overall increase ...
Tags: Minerals, Metallurgy, Energy
All dollar amounts stated below are in United States dollars. Third Quarter Ended March 31, 2012 Financial Highlights: The net loss for the third quarter ended March 31, 2012 totaled $5.3 million or $0.12 per share as compared to a net ...
Tags: Rare Element, financial results, net loss
By Adam Currie — Exclusive to Rare Earth Investing News Investor focus shifted east this week as market speculators made it known that they believe China will boost rare earth output to take advantage of potential near-term price ...
The European Commission (EC) has granted marketing authorization to Pfizer's INLYTA (axitinib) oral therapy, designed to treat adult patients with advanced renal cell carcinoma (RCC). INLYTA, a kinase inhibitor, is designed to ...
Bracco Diagnostics (BDI) has recalled nine lots of Isovue PFS injector syringes, to be used in combination with stellant CT injection systems due to the presence of visible particles in syringes in the US. The particles were observed at ...
Tags: Bracco Diagnostics, injector syringe, stellant CT injection systems
Novartis has won FDA approval for Afinitor (everolimus) tablets for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ breast cancer) in combination with exemestane after ...
The US Food and Drug Administration (FDA) has approved Genentech's Perjeta (pertuzumab) for the treatment of HER2-positive metastatic breast cancer (mBC), in combination with Herceptin (trastuzumab) and docetaxel chemotherapy. The ...
Tags: FDA approval, breast cancer, clinical study, pharmaceutical product
Exelixis has completed the submission of new drug application (NDA) for cabozantinib as a treatment for progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC) patients, with the FDA. Cabozantinib is ...
Tags: submission of new drug application, FDA, pharmaceutical product